The study of more than one million participants found that post menopausal women using the combined oestrogen-progestagen treatment were at a greater risk than those using other types of HRT.

Researchers found that using the combined oestrogen-progestagen treatment - the most common form of HRT - doubled women's risk of developing breast cancer compared with those not taking HRT.

She said the risk of coronary heart disease, stroke and ovarian and endometrial cancer was no higher among women aged 45 and ...

HRT can be taken as a combination pill or patch. Both hormones can be taken every day (continuous combined schedule), or estrogen can be taken alone most days with progestogen added for part of the ...

Combined hormone therapy may involve continuously taking estrogen and progestin every day. Your provider may also suggest ...

She said the risk of coronary heart disease, stroke and ovarian and endometrial cancer was no higher among women aged 45 and over taking combined HRT, compared to those who had never taken it.

The study will monitor utilization practice with particular attention to long-term effects in user cohorts of: 1) Angeliq (and potentially of other novel oral continuous-combined HRT products); 2 ...

For women with a uterus (and therefore an endometrial lining), progestin-estrogen replacement therapy (PERT) with cyclic or continuous progestin ... bleeding on cyclic HRT; others accept the ...